Novartis AG Statistics
Total Valuation
Novartis AG has a market cap or net worth of 277.36 billion. The enterprise value is 318.55 billion.
| Market Cap | 277.36B |
| Enterprise Value | 318.55B |
Important Dates
The last earnings date was Tuesday, April 28, 2026.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | Mar 10, 2026 |
Share Statistics
| Current Share Class | 1.91B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -3.80% |
| Shares Change (QoQ) | -0.67% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 43.83% |
| Float | 1.82B |
Valuation Ratios
The trailing PE ratio is 20.49 and the forward PE ratio is 16.19.
| PE Ratio | 20.49 |
| Forward PE | 16.19 |
| PS Ratio | 4.90 |
| PB Ratio | 7.13 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 15.82 |
| P/OCF Ratio | 14.46 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.51, with an EV/FCF ratio of 18.17.
| EV / Earnings | 23.54 |
| EV / Sales | 5.54 |
| EV / EBITDA | 13.51 |
| EV / EBIT | 17.02 |
| EV / FCF | 18.17 |
Financial Position
The company has a current ratio of 0.85, with a Debt / Equity ratio of 1.21.
| Current Ratio | 0.85 |
| Quick Ratio | 0.53 |
| Debt / Equity | 1.21 |
| Debt / EBITDA | 2.03 |
| Debt / FCF | 2.68 |
| Interest Coverage | 15.14 |
Financial Efficiency
Return on equity (ROE) is 34.93% and return on invested capital (ROIC) is 21.10%.
| Return on Equity (ROE) | 34.93% |
| Return on Assets (ROA) | 10.54% |
| Return on Invested Capital (ROIC) | 21.10% |
| Return on Capital Employed (ROCE) | 21.14% |
| Weighted Average Cost of Capital (WACC) | 6.41% |
| Revenue Per Employee | 751,697 |
| Profits Per Employee | 179,813 |
| Employee Count | 75,267 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 2.28 |
Taxes
In the past 12 months, Novartis AG has paid 2.27 billion in taxes.
| Income Tax | 2.27B |
| Effective Tax Rate | 14.38% |
Stock Price Statistics
The stock price has increased by +30.15% in the last 52 weeks. The beta is 0.52, so Novartis AG's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | +30.15% |
| 50-Day Moving Average | 151.48 |
| 200-Day Moving Average | 124.73 |
| Relative Strength Index (RSI) | 45.20 |
| Average Volume (20 Days) | 120,909 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novartis AG had revenue of 56.58 billion and earned 13.53 billion in profits. Earnings per share was 6.98.
| Revenue | 56.58B |
| Gross Profit | 42.75B |
| Operating Income | 18.42B |
| Pretax Income | 15.78B |
| Net Income | 13.53B |
| EBITDA | 22.92B |
| EBIT | 18.42B |
| Earnings Per Share (EPS) | 6.98 |
Balance Sheet
The company has 6.89 billion in cash and 47.00 billion in debt, giving a net cash position of -40.11 billion.
| Cash & Cash Equivalents | 6.89B |
| Total Debt | 47.00B |
| Net Cash | -40.11B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 38.93B |
| Book Value Per Share | 20.18 |
| Working Capital | -4.77B |
Cash Flow
In the last 12 months, operating cash flow was 19.18 billion and capital expenditures -1.64 billion, giving a free cash flow of 17.54 billion.
| Operating Cash Flow | 19.18B |
| Capital Expenditures | -1.64B |
| Depreciation & Amortization | 4.50B |
| Net Borrowing | 14.53B |
| Free Cash Flow | 17.54B |
| FCF Per Share | n/a |
Margins
Gross margin is 75.55%, with operating and profit margins of 32.56% and 23.92%.
| Gross Margin | 75.55% |
| Operating Margin | 32.56% |
| Pretax Margin | 27.90% |
| Profit Margin | 23.92% |
| EBITDA Margin | 40.51% |
| EBIT Margin | 32.56% |
| FCF Margin | 30.99% |
Dividends & Yields
This stock pays an annual dividend of 4.75, which amounts to a dividend yield of 3.28%.
| Dividend Per Share | 4.75 |
| Dividend Yield | 3.28% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 64.15% |
| Buyback Yield | 3.80% |
| Shareholder Yield | 7.07% |
| Earnings Yield | 4.88% |
| FCF Yield | 6.32% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Novartis AG has an Altman Z-Score of 3.27 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.27 |
| Piotroski F-Score | 5 |